Overview

• Rep. Robert Bresnahan sold shares in Centene, a leading Medicaid managed-care provider, just before voting to advance President Trump’s budget plan that includes $1 trillion in Medicaid cuts over the next decade.
• Quiver Quantitative reports that Centene’s stock has fallen approximately 43 percent since his sale on July 1.
• Despite promising to transfer his assets into a qualified blind trust, the Pennsylvania representative has not done so as of July 3.
• Roughly 27 percent of constituents in Pennsylvania’s 17th District rely on Medicaid, intensifying conflict of interest concerns.
• Lawmakers from both parties and ethics watchdogs are renewing calls for a ban on congressional stock trading.